Serum visfatin, an adipokine positively associated with an adverse metabolic profile in obesity [27, 108, 299], exerts proliferative effects and induces resistance to chemotherapy in AML cells in vitro [218]. The gene discussed is NAMPT; the disease is obesity disorder.